StockStory.org on MSN
The 5 most interesting analyst questions from Amgen’s Q4 earnings call
Amgen’s fourth-quarter results reflected broad-based sales growth across its diverse portfolio, with management crediting ...
We tapped Kira Igbowu, a licensed esthetician and beauty industry expert, on the consequences of overusing pimple patches, ...
An eczema drug from Nektar Therapeutics maintained skin responses in a one-year study, meeting and in some cases exceeding ...
In a federally funded clinical trial led by Johns Hopkins Medicine, people with tuberculosis infections (but not HIV) in two ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results